Rethinking Prior Authorization: What Patients and Physicians Need to Know
Welcome back to Health Tech Checkup! Hosts Perry Dimas and Rachelle Galant are joined by Dr. Michael Ybarra, Chief Medical Officer at PhRMA and a practicing emergency room physician, for a conversation that bridges two worlds rarely held by the same person: the immediacy of bedside emergency medicine and the slow, high-stakes grind of federal health policy. Dr. Ybarra traces his path from ER residency "side hustle" to full-time health policy leader, and explains why staying connected to clinical practice still shapes how he thinks about the rules coming out of Washington. He shares two moments that stuck with him — a vaccine-preventable meningitis death in his own department, and the realization, years into practice, that cystic fibrosis patients had all but stopped showing up in his ER thanks to a new generation of treatments — as reminders that today's standard of care isn't the ceiling. The conversation turns to prior authorization, where Dr. Ybarra cites data that seven out of ten initial requests for branded medicines are denied, and that physicians and staff still spend roughly 13 hours a week on the process. He makes the case that friction in the system carries real costs that don't show up on an insurer's spreadsheet including clinician burnout, delayed care, and patients left waiting on treatments that are usually approved anyway. Perry, Rachel and Dr. Ybarra also dig into: The "three-legged stool" Dr. Ybarra says is required to sustain a healthy biopharmaceutical innovation pipeline: a stable regulatory environment, strong IP protections, and a reimbursement system that rewards successful innovation How AI is already being used at the local level — from in-house EHR tools to personal GPT workflows — to reduce the administrative friction clinicians face every day The 340B drug pricing program: what it was designed to do, how hospital markups are distorting it, and why Michael says reform is needed to make sure savings actually reach patients Direct-to-patient pricing models and price transparency tools Plus: why the fax machine is "the glue that holds the U.S. healthcare system together," what Dr. Ybarra hopes the next 10 years of medicine will make obsolete, and why he believes today's death sentence doesn't have to be tomorrow's. —------- Keep in touch with our hosts, Rachelle Galant and Perry Dimas on Linkedin! To learn more about careviso, visit, www.careviso.com